Multivalent S2-based vaccines provide broad protection against SARS-CoV-2 variants of concern and pangolin coronaviruses
Peter Halfmann(University of Wisconsin–Madison), Ravi S. Kane(Georgia Institute of Technology), Ralph S. Baric(University of North Carolina at Chapel Hill), Tadashi Maemura(University of Wisconsin–Madison), Yixuan J. Hou(University of North Carolina at Chapel Hill), Steven J. Frey(Georgia Institute of Technology), Makoto Kuroda(National Institute of Infectious Diseases), Tammy Armbrust(University of Wisconsin–Madison), Yoshihiro Kawaoka(University of Wisconsin–Madison), Elizabeth Wright(University of Wisconsin System), Jie Yang(Xijing Hospital), Kathryn Loeffler(Georgia Institute of Technology)
Cited by 64
Related Papers
Comparative therapeutic efficacy of remdesivir and combination lopinavir, ritonavir, and interferon beta against MERS-CoV
|Nature Communications|2020|1.8k
Experimental adaptation of an influenza H5 HA confers respiratory droplet transmission to a reassortant H5 HA/H1N1 virus in ferrets
|Nature|2012|1.5k
Commentary: Middle East Respiratory Syndrome Coronavirus (MERS-CoV): Announcement of the Coronavirus Study Group
|Journal of Virology|2013|1.3k
Aberrant innate immune response in lethal infection of macaques with the 1918 influenza virus
|Nature|2007|939
Animal models for COVID-19
|Nature|2020|877